CASI Pharmaceuticals, Inc. (CASI)
NASDAQ: CASI · Real-Time Price · USD
1.310
-0.201 (-13.30%)
At close: Sep 26, 2025, 4:00 PM EDT
1.319
+0.009 (0.70%)
After-hours: Sep 26, 2025, 7:58 PM EDT
CASI Pharmaceuticals Market Cap
CASI Pharmaceuticals has a market cap or net worth of $20.30 million as of September 26, 2025. Its market cap has decreased by -82.14% in one year.
Market Cap
20.30M
Enterprise Value
32.27M
1-Year Change
-82.14%
Ranking
Category
Stock Price
$1.31
Market Cap Chart
Since June 12, 1996, CASI Pharmaceuticals's market cap has decreased from $101.76M to $20.30M, a decrease of -80.06%. That is a compound annual growth rate of -5.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 20.30M | -53.71% |
| Dec 31, 2024 | 43.84M | -54.03% |
| Dec 29, 2023 | 95.38M | 291.63% |
| Dec 30, 2022 | 24.35M | -78.22% |
| Dec 31, 2021 | 111.84M | -69.41% |
| Dec 31, 2020 | 365.63M | 22.82% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 650.45B |
| Johnson & Johnson | 432.80B |
| AbbVie | 389.72B |
| UnitedHealth Group | 311.62B |
| Novo Nordisk | 242.68B |
| Novartis AG | 238.65B |
| Abbott Laboratories | 232.44B |
| AstraZeneca | 228.75B |